We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $157M
1-Year Est. Return 60.08%
This Fund
S&P 500
This Quarter Est. Return
+22.85%
1 Year Est. Return
+60.08%
3 Year Est. Return
+110.48%
5 Year Est. Return
+186.03%
10 Year Est. Return
–
AUM
$157M
AUM Growth
+$37.8M
Cap. Flow
+$16.4M
Cap. Flow %
10.39%
Top 10 Hldgs %
34.75%
Holding
84
New
13
Increased
27
Reduced
9
Closed
13

Top Buys

Rank Stock Value
1
ADSK icon
Autodesk
ADSK
+$2.85M
2
DIS icon
Walt Disney
DIS
+$2.55M
3
EG icon
Everest Group
EG
+$2.23M
4
WGO icon
Winnebago Industries
WGO
+$1.98M
5
MTN icon
Vail Resorts
MTN
+$1.95M

Top Sells

Rank Stock Value
1
INTT icon
inTEST
INTT
+$4.5M
2
CRL icon
Charles River Laboratories
CRL
+$3.02M
3
THFF icon
First Financial Corp
THFF
+$1.9M
4
ALK icon
Alaska Air
ALK
+$1.84M
5
HPQ icon
HP
HPQ
+$1.73M

Sector Composition

Rank Sector Weight
1 Healthcare 37.03%
2 Consumer Discretionary 11.85%
3 Financials 11.43%
4 Technology 10.35%
5 Industrials 9.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NWL icon
51
Newell Brands
NWL
$2.63B
$1.23M 0.78%
200,000
– –
CMPX icon
52
Compass Therapeutics
CMPX
$432M
$1.2M 0.77%
+550,000
New +$1.62M
GNLX icon
53
Genelux
GNLX
$120M
$1.2M 0.76%
400,000
+150,000
+60% +$424K
PROF
54
Profound Medical
PROF
$250M
$1.16M 0.74%
175,000
– –
GUTS icon
55
Fractyl Health
GUTS
$105M
$1.11M 0.71%
1,400,000
– –
DIT icon
56
AMCON Distributing
DIT
$984K 0.63%
13,518
+18
+0.1% +$1.52K
CRGY icon
57
Crescent Energy
CRGY
$4.47B
$982K 0.62%
+100,000
New +$1.22M
TALO icon
58
Talos Energy
TALO
$2.78B
$968K 0.62%
+75,000
New +$1.12M
SAIC icon
59
Saic
SAIC
$5.33B
$883K 0.56%
+8,000
New +$809K
CGNT icon
60
Cognyte Software
CGNT
$650M
$878K 0.56%
100,000
-75,000
-43% -$711K
BMRN icon
61
BioMarin Pharmaceuticals
BMRN
$12.5B
$858K 0.55%
+15,000
New +$822K
OSTX
62
OS Therapies Inc
OSTX
$76.2M
$760K 0.48%
400,000
– –
RNAC icon
63
Cartesian Therapeutics
RNAC
$290M
$625K 0.4%
+60,000
New +$444K
SVC
64
Service Properties Trust
SVC
$1.02B
$592K 0.38%
70,000
-30,000
-30% -$236K
CTSO icon
65
Cytosorbents Corp
CTSO
$21.1M
$552K 0.35%
1,476,500
– –
CGTX icon
66
Cognition Therapeutics
CGTX
$97M
$518K 0.33%
450,000
+50,000
+13% +$59.2K
PFE icon
67
Pfizer
PFE
$159B
$482K 0.31%
+20,000
New +$523K
HRTX icon
68
Heron Therapeutics
HRTX
$62M
$427K 0.27%
1,000,000
– –
NVNO
69
enVVeno Medical
NVNO
$7.47M
$382K 0.24%
35,714
– –
BCDA icon
70
BioCardia
BCDA
$17.4M
$372K 0.24%
300,000
+170,000
+131% +$179K
CRIS icon
71
Curis
CRIS
$3.61M
$287K 0.18%
27,500
+20,000
+267% +$205K
ALK icon
72
Alaska Air
ALK
$4.72B
– –
-50,000
Closed -$1.84M
ASRT
73
DELISTED
Assertio
ASRT
– –
-35,000
Closed -$667K
CRL icon
74
Charles River Laboratories
CRL
$13.9B
– –
-17,500
Closed -$3.02M
CWH icon
75
Camping World
CWH
$417M
– –
-60,000
Closed -$410K
1 2
3
4

Similar funds

SFSG
Sound Financial Strategies Group Madison, Mississippi $157M AUM 15.51% 1-Year Est. Return
PTFIS
Pekao Towarzystwo Funduszy Inwestycyjnych SA Warsaw $157M AUM
AWMG
ADG Wealth Management Group Metairie, Louisiana $158M AUM 18.25% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $158M AUM 33.7% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
DFS
Demming Financial Services Aurora, Ohio $157M AUM
APW
Aurora Private Wealth Rockaway, New Jersey $158M AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return

CM Management's Q2 2026 Portfolio in Review

As of Q2 2026, CM Management held 84 positions worth $157M, up 32% from $120M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

CM Management deployed $16.4M of net new capital in Q2 2026, opening 13 new positions and adding to 27 existing holdings. Its largest new stake was Autodesk: 12,500 shares worth $2.43M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Organon & Co, an estimated $1.49M trimmed.

  • CM Management's largest Q2 2026 buy was Autodesk: 12,500 shares worth $2.43M.
  • CM Management added most to Everest Group in Q2 2026, an estimated $2.23M increase.
  • CM Management's biggest Q2 2026 reduction was Organon & Co, cutting an estimated $1.49M.
  • CM Management fully exited inTEST in Q2 2026, selling an estimated $4.5M.
  • CM Management's ten largest holdings make up 35% of its $157M portfolio in Q2 2026.
  • CM Management opened 13 new positions and closed 13 in Q2 2026.
  • CM Management's portfolio value rose 32% quarter-over-quarter to $157M.

Based on CM Management's 13F filing for Q2 2026, filed 13 Aug 2026.